Cargando…

High score on PREDICTS is associated with 10-fold increased odds for the progression of subclinical atherosclerosis in SLE

Detalles Bibliográficos
Autores principales:	McMahon, M, Sahakian, Lori, Grossman, J, Skaggs, B, Fitzgerald, J, Charles-Schoeman, C, Ragavendra, N, Gorn, A, Karpouzas, G, Weisman, M, Wallace, D, Hahn, B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3467527/ http://dx.doi.org/10.1186/ar3984

Ejemplares similares

Comparison of PREDICTS atherosclerosis biomarker changes after initiation of new treatments in patients with SLE
por: McMahon, Maureen, et al.
Publicado: (2019)

High plasma leptin levels confer increased risk of atherosclerosis in women with systemic lupus erythematosus, and are associated with inflammatory oxidised lipids
por: McMahon, Maureen, et al.
Publicado: (2011)

A Panel of Biomarkers Associates With Increased Risk for Cardiovascular Events in Women With Systemic Lupus Erythematosus
por: Skaggs, Brian J., et al.
Publicado: (2021)

Relationship between retinal microvascular impairment and subclinical atherosclerosis in SLE
por: Ferrigno, Sara, et al.
Publicado: (2023)

Altered lipoprotein metabolism in chronic inflammatory states: proinflammatory high-density lipoprotein and accelerated atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis
por: Hahn, Bevra H, et al.
Publicado: (2008)

Assessing the validity of QRISK3 in predicting cardiovascular events in systemic lupus erythematosus
por: Zhu, Lisa, et al.
Publicado: (2022)

Study of common hypertriglyceridaemia genetic variants and subclinical atherosclerosis in a group of women with SLE and a control group
por: Fanlo-Maresma, Marta, et al.
Publicado: (2022)

Progression of subclinical and clinical cardiovascular disease in a UK SLE cohort: the role of classic and SLE-related factors
por: Haque, Sahena, et al.
Publicado: (2018)

Daily Sitting for Long Periods Increases the Odds for Subclinical Atheroma Plaques
por: Perez-Lasierra, Jose Luis, et al.
Publicado: (2021)

The Origins and Functions of De Novo Genes: Against All Odds?
por: Weisman, Caroline M.
Publicado: (2022)

Subclinical atherosclerosis in patients with psoriasis
por: Balta, Ilknur, et al.
Publicado: (2015)

Diabetes and Subclinical Coronary Atherosclerosis
por: Lee, Chang Hoon, et al.
Publicado: (2018)

Predictors of subclinical atherosclerosis in HIV
por: Fernández Soto, Julia, et al.
Publicado: (2023)

Atherosclerosis in SLE: a potential role for serum parathormone levels
por: Giannelou, Mayra, et al.
Publicado: (2020)

Associations of urinary isoprostanes with measures of subclinical atherosclerosis: The Multi-Ethnic Study of Atherosclerosis (MESA)
por: Wallace, Ryan L., et al.
Publicado: (2022)

Right Ventricular Subclinical Dysfunction in SLE Patients Correlates with Metabolomic Fingerprint and Organ Damage
por: Deidda, Martino, et al.
Publicado: (2023)

Noninvasive indicators of atherosclerosis in subclinical hypothyroidism
por: Kilic, Ismail Dogu, et al.
Publicado: (2013)

Association of Fat Density With Subclinical Atherosclerosis
por: Alvey, Nicholas J., et al.
Publicado: (2014)

Subclinical atherosclerosis: how and when to treat it?
por: Gatto, Laura, et al.
Publicado: (2020)

Biomarkers of subclinical atherosclerosis in patients with psoriasis
por: Kaiser, Hannah, et al.
Publicado: (2021)

Thinking toward improved treatments of systemic lupus erythematosus
por: Hahn, BH, et al.
Publicado: (2012)

M3 transition in odd and odd-odd nuclei
por: Roussière, B, et al.
Publicado: (1996)

Cardiorespiratory fitness decreases the odds for subclinical carotid plaques in apolipoprotein e4 homozygotes
por: Perez-Lasierra, Jose Luis, et al.
Publicado: (2022)

Oxidative folding pathways of bovine milk β‐lactoglobulin with odd cysteine residues
por: Iwaoka, Michio, et al.
Publicado: (2019)

Subclinical Atherosclerosis and Obesity Phenotypes Among Mexican Americans
por: Laing, Susan T., et al.
Publicado: (2015)

Biomarkers of Subclinical Atherosclerosis in Patients with Autoimmune Disorders
por: Profumo, Elisabetta, et al.
Publicado: (2012)

The Association between Subclinical Atherosclerosis and Uterine Fibroids
por: He, Yuan, et al.
Publicado: (2013)

P01-014 – Subclinical atherosclerosis in FMF
por: Ugurlu, S, et al.
Publicado: (2013)

The Association between Air Pollution and Subclinical Atherosclerosis
por: Kawada, Tomoyuki
Publicado: (2014)

Frequency of Subclinical Atherosclerosis in HIV-infected Brazilians
por: Uip, David Everson
Publicado: (2018)

Subclinical Atherosclerosis Imaging in People Living with HIV
por: Schoepf, Isabella C., et al.
Publicado: (2019)

Biomarkers of subclinical atherosclerosis in patients with psoriatic arthritis
por: Peluso, Rosario, et al.
Publicado: (2019)

Subclinical thyroid dysfunction and risk of carotid atherosclerosis
por: Kim, Hosu, et al.
Publicado: (2017)

Early Pregnancy Cardiovascular Health and Subclinical Atherosclerosis
por: Benschop, Laura, et al.
Publicado: (2019)

Variability of the Plasma Lipidome and Subclinical Coronary Atherosclerosis
por: Tan, Sock Hwee, et al.
Publicado: (2021)

Assessment of plasma ceramides as predictor for subclinical atherosclerosis
por: Mishra, Pashupati P., et al.
Publicado: (2021)

SLE - Practical and theoretical barriers to the prevention of accelerated atherosclerosis in systemic lupus erythematosus
por: Costenbader, Karen H, et al.
Publicado: (2003)

Myocardial infarctions, subtypes and coronary atherosclerosis in SLE: a case–control study
por: Samuelsson, Isak, et al.
Publicado: (2021)

SARS-CoV-2 infection and SLE: endothelial dysfunction, atherosclerosis, and thrombosis
por: Płazak, Wojciech, et al.
Publicado: (2023)

Generic and disease-adapted cardiovascular risk scores as predictors of atherosclerosis progression in SLE
por: Panopoulos, Stylianos, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lc61u3n7fc2fdscack81s756kk